📰 Cellorigin Biotech News
Cellorigin Biotech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cellorigin Biotech. Real-time updates on events, politics, business and more.
September 27, 2022
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy - read this article along with other careers information, tips and advice on BioSpace
September 26, 2022
/PRNewswire/ -- CellOrigin Biotech (Hangzhou) Co., Ltd. announced it has made a global strategic collaboration agreement with Qilu Pharma to develop,...
September 26, 2022
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy
September 12, 2022
Beijing BoomRay Pharma has completed a $43 million Series A funding to develop novel radionuclide drugs that integrate diagnosis and treatment. Read more here...
September 11, 2022
CellOrigin Biotech announced strategic global collaboration with Qilu Pharmaceutical to develop "off-the-shelf" CAR-iMAC cell therapy - read this article along with other careers information, tips and advice on BioSpace
September 6, 2022
CellOrigin Biotech announced strategic global collaboration with Qilu Pharmaceutical to develop "off-the-shelf" CAR-iMAC cell therapy
September 5, 2022
/PRNewswire/ -- CellOrigin Biotech (Hangzhou) Co., Ltd. announced that it has made an agreement with Qilu Pharmaceutical on strategic global collaborations to...
October 15, 2021
/PRNewswire/ -- On Oct. 11th, 2021, CellOrigin Inc. released data about its second generation of iPSC-CAR-Macrophage which has a genetically integrated...